Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinusitis Hevert SL in acute rhinosinusitis
DRKS00006877Phase 4Completed
- Sponsor
- Hevert-Arzneimittel
- Start
- Nov 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute rhinosinusitis (ARS) comparing Sinusitis Hevert SL with Placebo (2 arms). Started Nov 2014; status: completed.
02
Drugs
Sinusitis Hevert SL
03
Conditions
acute rhinosinusitis (ARS)
Beyond the preview
Go deeper on DRKS00006877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00006877.